» Articles » PMID: 12451624

Prognostic Factors of Hepatic Resection for Hepatocellular Carcinoma with Cirrhosis: Univariate and Multivariate Analysis

Overview
Journal J Surg Oncol
Date 2002 Nov 27
PMID 12451624
Citations 68
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Objectives: The objective of this investigation was to study the clinicopathological factors influencing long-term outcome of hepatocellular carcinoma (HCC) with liver cirrhosis in patients undergoing hepatectomy. Liver cirrhosis, especially the macronodular variety, has been found in up to 90% of patients with HCC. In Asia, the incidence of liver cirrhosis in patients with HCC who had undergone hepatic resection varies from 42.5% to 73.8%. However, the optimal surgical approach for HCC patients with cirrhosis is less clearly defined. Resection of the cirrhotic liver is challenging and remains controversial in the treatment of HCC.

Methods: This study retrospectively analyzed the surgical outcomes of HCC concomitant with liver cirrhosis in 218 patients who underwent hepatic resection between 1986 and 1998. Post-resection prognostic factors were assessed using a univariate log-rank test and a multivariate Cox proportional hazards model.

Results: The overall postoperative complication rate was 15.6%, while the surgical mortality rate was 8.8%. Meanwhile, the 1-, 3-, and 5-year disease-free survival rates were 50.9%, 33.98%, and 27.03%, respectively, and. the overall cumulative survival rates at 1, 3, and 5 years were 63.14%, 41.88%, and 31.83%, respectively. Applying Cox's multivariate proportional hazard model indicated that significant adverse prognostic indicators included elevated alkaline phosphatase value, tumor size >2 cm, presence of satellite lesions, and vascular invasion.

Conclusions: This investigation found that overall survival for HCC patients concomitant with liver cirrhosis who underwent hepatic resection should be stratified on the basis of the high value of alkaline phosphatase, tumor size, satellite lesions, and vascular invasion.

Citing Articles

A predictive model based on radiomics, clinical features, and pathologic indicators for disease-free survival after liver transplantation for hepatocellular carcinoma: a 7-year retrospective study.

Xie H, Shi B, Fan J, Liu S, Ma Q, Dai J J Gastrointest Oncol. 2024; 15(5):2187-2200.

PMID: 39554565 PMC: 11565123. DOI: 10.21037/jgo-24-347.


Clinical significances of several fibrotic markers for prognosis in hepatocellular carcinoma patients who underwent hepatectomy.

Nanashima A, Hiyoshi M, Imamura N, Hamada T, Tsuchimochi Y, Shimizu I Transl Cancer Res. 2024; 13(5):2332-2345.

PMID: 38881924 PMC: 11170533. DOI: 10.21037/tcr-24-94.


Stage-by-stage analysis of the effect of blood transfusion on survival after curative hepatectomy for hepatocellular carcinoma-a retrospective study.

She W, Tsang S, Dai W, Chan A, Lo C, Cheung T Langenbecks Arch Surg. 2024; 409(1):83.

PMID: 38436871 DOI: 10.1007/s00423-024-03278-z.


Prognostic Factors for Patients with Proliferative Hepatocellular Carcinoma After Liver Resection.

Li H, Huang W, Hu C, Zhang Z, Xiao Y, Wang T J Hepatocell Carcinoma. 2023; 10:2059-2071.

PMID: 38022727 PMC: 10675999. DOI: 10.2147/JHC.S440636.


Subcentimeter hepatocellular carcinoma (HCC) on gadoxetic-acid-enhanced MRI: less frequent typical imaging features compared to 1-2 cm HCC but better prognosis after surgical resection.

Huang P, Shi Q, Ni X, Liu L, Zhou C, Wu F Abdom Radiol (NY). 2023; 48(11):3391-3400.

PMID: 37656218 DOI: 10.1007/s00261-023-04024-7.